SOMERSET, N.J., June 13 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. announced today that it will host a conference focused on the challenges facing pharmaceutical sales and marketing managers in today's environment. The event - "Innovation in Today's Pharmaceutical Environment" - will feature a series of presentations given by inVentiv Health management as well as guest speakers from the pharmaceutical industry including Roger Longman, Managing Partner of Windhover Information, Inc. and editor of In Vivo magazine. The half-day conference is part of the inVentiv Pharma Forum conference series.
The conference will take place on Thursday, June 21, 2007 at the Grand Summit Hotel located at 570 Springfield Avenue, Summit, New Jersey. Registration and breakfast will begin at 8:30 a.m. Lunch will be served at 12:15 p.m. during a panel discussion. The event is scheduled to end by 2:00 p.m.
Hosted by Terry Herring, President and CEO of inVentiv Commercial and COO of inVentiv Health, conference presentations will cover competitive pressures driving change in the sales and marketing area, strategies for customizing the new field force, opportunities for creating deeper connections with customers and the outlook for the industry including prevalent trends in the current environment. In addition to Mr. Longman, speakers include Phil Deschamps, President and CEO, GSW Worldwide and Paul Mignon, President and COO, Ventiv Pharma Teams.
Mr. Longman will also moderate a panel discussion over lunch involving the aforementioned speakers as well as Jaye L. Thompson, PhD - Senior VP, inVentiv Clinical Solutions, and Denice Torres - VP, Marketing - Ortho-McNeil Neurologics.
Commenting on the relevance of the event in today's marketplace, Terry Herring, said, "Market dynamics and innovation to keep up with the changes taking place is something we discuss quite often with our clients. As a result, we thought we would design an open forum in which sales and marketing professionals can discuss the challenges of the changing industry environment and we can share insights on new sales and marketing models for overcoming these challenges. We welcome all of our clients and representatives from the pharmaceutical industry to join us in what will certainly be a highly engaging discussion."
For more information about the inVentiv Pharma Forum event or to sign up for the event, please email
About inVentiv Health
inVentiv Health is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit http://www.inventivhealth.com/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
